2011-11-08T09:57:04-06:00 2010-12-31 O'CONNOR DAVIES MUNNS & DOBBINS LLP 500 MAMARONECK AVENUE - SUITE 301 HARRISON NY 105281633 990 2010-01-01 223419667 INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE INC INTE 2125005724 61 BROADWAY NO 1720 NEW YORK NY 10006 JOSE LUIS CASTRO 2125005724 2011-11-08 1 GARRETT M HIGGINS CPA 9143818900 2010 2016-03-07 17:11:31Z JOSE LUIS CASTRO 61 BROADWAY NO 1720 NEW YORK NY 10006 20296749 0 X WWW.THEUNION.ORG X 1995 NJ IUATLD,INC. IS A FULLY REGISTERED NON-PROFIT, PUBLIC CHARITY ORGANIZATION BASED IN NEW YORK CITY AND SERVES AS THE NORTH AMERICAN AFFILIATE OF THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE (THE UNION), HEADQUARTERED IN PARIS, FRANCE. DURING TAX YEAR 2010 (JANUARY-DECEMBER 2010), THE ORGANIZATION UNDERTOOK SEVERAL MAJOR ACTIVITIES RELATED TO BOTH ORGANIZATIONAL DEVELOPMENT AND PROGRAMMATIC INITIATIVES. THIS STATEMENT DESCRIBES THE MAJOR ACTIVITIES UNDERTAKEN AND ACCOMPLISHMENTS ACHIEVED. TECHNICAL PROJECT ACTIVITY 1: DEVELOPING THE EVIDENCE BASE FOR DIAGNOSTIC TOOLSKEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE THE: A. FINALIZATION AND DISSEMINATION OF THE REPORT AND RESEARCH AGENDA FROM GLOBAL CONSULTATION ON DIGITAL RADIOGRAPHY. THE TEAM ALSO CONDUCTED ADDITIONAL RESEARCH FOR AN OPINION PIECE, WHICH IS SCHEDULED TO BE SUBMITTED FOR PUBLICATION IN 2011. 3 1 7 1 0 0 19419094 20284523 0 0 11877 12005 0 221 19430971 20296749 17761636 19009023 0 0 1040011 953244 0 0 0 560767 499175 19362414 20461442 68557 -164693 1784765 2496697 1693559 2570184 91206 -73487 X THE UNION BRINGS INNOVATION, EXPERTISE, SOLUTIONS AND SUPPORT TO ADDRESS HEALTH CHALLENGES IN LOW AND MIDDLE INCOME POPULATIONS. OUR VISION IS TO DEVELOP HEALTH SOLUTIONS FOR THE POOR. OUR VALUES INCLUDE:1. QUALITY: WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST POSSIBLE STANDARDS.2. ACCOUNTABILITY: WE ARE RESPONSIBLE STEWARDS OF RESOURCES AND DELIVER ON OUR COMMITMENTS.3. INDEPENDENCE: WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION, AND ARE GUIDED BY THE BEST EVIDENCE TO IMPROVE THE HEALTH OF THE POOR4. SOLIDARITY: WE STAND TOGETHER AS ONE UNION TO OVERCOME THE GREATEST CHALLENGES TO IMPROVE HEALTH AMONG THE COMMUNITIES WE SERVE. 0 0 19515600 19009023 TOBACCO CONTROL:IUATLD, INC. WAS THE RECIPIENT OF OVER $16 MILLION IN GRANT FUNDING FROM THE WORLD LUNG FOUNDATION FOR SUPPORT OF THE UNION'S PARTICIPATION IN THE HIGHLY SUCCESSFUL BLOOMBERG INITIATIVE TO REDUCE TOBACCO USE. THROUGH ITS REGIONAL OFFICES IN EUROPE, LATIN AMERICA, SOUTH-EAST ASIA, THE MIDDLE EAST AND ASIA PACIFIC, THE UNION USES THESE GRANT FUNDS TO EFFECTIVELY WORK WITH GOVERNMENTS IN 14 OF THE WORLD'S TOP TOBACCO-USING COUNTRIES TO DEVELOP STRONGER TOBACCO CONTROL POLICIES AND LAWS. THE UNION IS THE CO-MANAGER OF THE BI GRANTS PROGRAM, AND SINCE 2007, HAS ISSUED GRANTS TO 73 TOBACCO CONTROL ORGANIZATIONS AND GOVERNMENTS IN 27 COUNTRIES. THE UNION HAS ALSO LAUNCHED A SERIES OF TECHNICAL AND MANAGEMENT COURSES DESIGNED SPECIFICALLY TO BUILD THE CAPACITY OF TOBACCO CONTROL ORGANIZATIONS, AND A WIDE RANGE OF RESOURCES FOR TOBACCO CONTROL ADVOCATES IS NOW AVAILABLE FROM THE UNION TO SUPPORT NATIONAL INITIATIVES SUCH AS TECHNICAL GUIDES FOR ESTABLISHING SMOKE-FREE HEALTH CARE FACILITIES AS WELL AS SCHOOLS AND SPORTING EVENTS, CASE STUDIES FOR SMOKE-FREE CITIES, ECONOMIC REPORTS RELATED TO TOBACCO-FREE INITIATIVES, AND FACT SHEETS. 101388 STRATEGIC HEALTH INFORMATION AND OPERATIONAL RESEARCH:IUATLD, INC. WAS THE RECIPIENT OF A $1,500,000 GRANT FROM AN ANONYMOUS DONOR TO SUPPORT THE UNION'S CENTRE FOR STRATEGIC HEALTH INFORMATION AND OPERATIONAL RESEARCH. THIS DONATION SUPPORTED THE ENHANCEMENT OF OPERATIONAL RESEARCH CAPACITY IN LOW- AND MIDDLE-INCOME COUNTRIES IN THE FIELD OF HIV/AIDS AND TB AS WELL AS KEY NON-COMMUNICABLE DISEASES SUCH AS ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, DIABETES MELLITUS AND HYPERTENSION. MANY OF THE TARGETED COUNTRIES FOR THIS INITIATIVE, PARTICULARLY IN AFRICA, ARE OVERBURDENED WITH SERIOUS COMMUNICABLE DISEASE EPIDEMICS AND GROWING EPIDEMICS OF NON-COMMUNICABLE DISEASES. MANY HAVE WEAK HEALTH INFORMATION SYSTEMS AND CANNOT MONITOR DISEASE BURDEN. IN ADDITION, OPERATIONAL RESEARCH (USING AVAILABLE DATA TO IMPROVE POLICY AND PRACTICE) IS LACKING BECAUSE FEW PROFESSIONALS HAVE ACCESS TO THE NECESSARY TRAINING, MENTORSHIP OR RESOURCES. BY THE END OF 2009, THROUGH THIS FUNDING, THE UNION WAS ABLE TO DEVELOP IMPROVED DATA COLLECTION AND TRACKING SYSTEMS FOR KEY COMMUNICABLE AND NON-COMMUNICABLE DISEASES BASED ON THE TUBERCULOSIS-DOTS MODEL, USE ELECTRONIC DATA SYSTEMS TO SUPPLEMENT AND/OR REPLACE PAPER RECORDS FOR MONITORING OF DISEASE BURDEN, INCREASE ADVOCACY AND CAPACITY FOR OPERATIONAL RESEARCH THROUGH CONFERENCE SYMPOSIA, A NEW MODEL OF OPERATIONAL RESEARCH TRAINING, OPERATIONAL RESEARCH FELLOWSHIPS AND STRATEGIC PARTNERSHIPS WITH ORGANIZATIONS ALREADY ENGAGED IN OPERATIONAL RESEARCH SUCH AS MEDECINS SANS FRONTIERES (MSF), ENHANCE VITAL REGISTRATION SYSTEMS SO THAT POPULATION IMPACT OF HEALTH INTERVENTIONS CAN BE ASSESSED, EVALUATE AND TRACK THE INFLUENCE OF OPERATIONAL RESEARCH AND STRATEGIC INFORMATION IN CHANGING POLICY AND PRACTICE, AND ENGAGE WITH THE WORLD HEALTH ORGANIZATION AND OTHER INTERNATIONAL ORGANIZATIONS TO MAXIMIZE THE BENEFITS OF THESE APPROACHES 614313 TREAT TB RESEARCH ACTIVITIES:IUATLD, INC. SERVED AS THE COORDINATING HUB FOR THE TREAT TB (TECHNOLOGY, RESEARCH, EDUCATION AND TECHNICAL ASSISTANCE FOR TUBERCULOSIS) INTERNATIONAL RESEARCH INITIATIVE SUPPORTED THROUGH A MULTI-YEAR COOPERATIVE AGREEMENT GRANT FROM THE UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID) TO THE UNION. AS THE CENTER FOR COORDINATION OF PROJECTS AND ACTIVITIES UNDER THE UNION-LED MULTI-PARTNER INITIATIVE, IUATLD, INC. PLAYED A MAJOR ROLE IN THE PLANNING OF TECHNICAL ACTIVITIES, RESEARCH COORDINATION, COMMUNICATIONS, AND PROJECT ADMINISTRATION. TREAT TB RESEARCH ACTIVITIES HAVE BEEN DESIGNED TO ASSIST LOW AND MIDDLE INCOME COUNTRIES TO ADOPT NEW AND IMPROVED DIAGNOSTIC TOOLS FOR TB, TO MORE EFFECTIVELY TREAT AND CURE MULTIDRUG-RESISTANT FORMS OF TB, AND TO UNDERTAKE OPERATIONAL RESEARCH TO IMPROVE HEALTH CARE POLICY, PRACTICE AND SERVICE DELIVERY. PUBLIC OPINION FOR ACTION AGAINST LUNG HEALTH PROBLEMS:THE INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE, INC. (IUATLD) RAISES PUBLIC AWARENESS OF AND SUPPORTIVE PUBLIC OPINION FOR INCREASED DOMESTIC AND FOREIGN ASSISTANCE TO COMBAT LUNG HEALTH CHALLENGES AMONG THE POOR IN LOW AND MIDDLE INCOME COUNTRIES FROM THE UNITED STATES GOVERNMENT, PRIVATE CHARITIES, FOUNDATIONS AND OTHER DONORS.EDUCATION AND TRAINING:IUATLD, INC. ORGANIZES AND/OR SUPPORTS IMPORTANT INTERNATIONAL CONFERENCES AND TRAINING PROGRAMS CONFERENCES AND TRAININGS ON TUBERCULOSIS, TOBACCO CONTROL, ASTHMA AND LUNG HEALTH AND WORKS TO INCREASE THE PARTICIPATION OF DOCTORS, NURSES, AND ALLIED HEALTH PERSONNEL FROM LOW AND MIDDLE INCOME COUNTRIES THROUGH THE PROVISION OF TECHNICAL SUPPORT, SCHOLARSHIPS AND TRAVEL GRANTS.PROJECT MANAGEMENT:IUATLD, INC. DIRECTLY MANAGES AND COORDINATES CAPACITY BUILDING, TECHNICAL ASSISTANCE AND RESEARCH PROJECTS FUNDED BY GOVERNMENTAL AND NON-GOVERNMENTAL DONORS IN COLLABORATION WITH MINISTRIES OF HEALTH AND NON-GOVERNMENTAL PARTNERS IN LOW AND MIDDLE INCOME COUNTRIES. THE UNION CONSIDERS ALL POTENTIAL PROJECTS AND DONATIONS IN THE CONTEXT OF OUR GUIDING VALUES: QUALITY (CAN WE DELIVER OUR SERVICES AND PRODUCTS TO THE HIGHEST ATTAINABLE STANDARDS?); ACCOUNTABILITY (CAN WE DEMONSTRATE RESPONSIBLE STEWARDSHIP OF RESOURCES AND DELIVER AND REPORT ON OUR COMMITMENTS?); INDEPENDENCE (DO WE MAINTAIN THE FREEDOM TO PURSUE INNOVATION AND SEEK EVIDENCE TO IMPROVE HEALTH AND MANAGEMENT SYSTEMS?); AND SOLIDARITY (CAN WE STAND TOGETHER TO OVERCOME GREAT CHALLENGES AND ACHIEVE BETTER HEALTH AMONG THE COMMUNITIES WE SERVE AND IN PARTICULAR FOR THE POOR?) 20231301 1 1 0 0 0 0 0 1 0 1 0 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 8 0 1 7 1 0 0 0 0 0 0 0 0 0 0 X 3 1 1 0 0 0 0 0 0 1 0 0 0 1 1 1 1 1 1 1 1 0 IL NJ NY X X X BLERTA SHEHU 2125005738 61 BROADWAY SUITE 1720 NEW YORK NY 10006 JOSE LUIS CASTRO 5.00 X X 0 99999 0 MARK D FUSSELL 40.00 X X 120577 0 27480 PETER BALDINI 1.00 X X 0 215002 0 MARIO PIERRO 1.00 X 0 0 0 PAULA FUJIWARA 40.00 X 250000 0 24969 JAY EVANS 40.00 X 110520 0 11602 481097 315001 64051 3 0 1 0 SYLVIANE RATTE 4 RUE LE BRUN PARIS FR 75013 INTL TOBACCO CONTROL CONSULTING SVCS 118000 1 17399523 2885000 20284523 12005 12005 INS. REBATES/REFUNDS 900099 221 221 221 20296749 0 0 12226 19009023 19009023 423026 397835 25191 417482 333535 83947 7794 5327 2467 48803 29831 18972 56139 56139 3319 3319 20076 8994 11082 176885 176885 22250 18700 3550 14667 14566 101 195133 129789 65344 24602 21929 2673 9953 9953 1068 1068 8426 8426 EQUIP RENTAL & REPAIR 18362 17270 1092 STAFF DEVLPMT & RECRUIT 4180 249 3931 OTHER EXPENSES 254 208 46 20461442 20231301 230141 0 1414838 75441 150902 462446 2944 1516523 57977 11470 3205 1738 1339 1467 156765 429350 1784765 2496697 58809 43630 1634750 2451623 74931 1693559 2570184 X 83192 -73487 8014 0 91206 -73487 1784765 2496697 -164693 0 X X 0 1 1 X 1 1 X 138551 16049 5279 19419094 20284523 39863496 138551 16049 5279 19419094 20284523 39863496 3680493 36183003 964 231 88 11877 12005 25165 221 221 39888882 0.90710 0.94330 X SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: SCHEDULE A, PART II, LINE 10, EXPLANATION FOR OTHER INCOME: REBATES & REFUNDS FOR INSURANCE PREMIUMS = $221.00 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 3205 1738 1467 1467 DUE FROM AFFILIATE - IUATLD, INC. (PARIS) 429350 429350 20296749 20461442 -164693 0 -164693 20296749 0 20296749 0 20296749 20461442 0 20461442 0 20461442 PART IV, LINE 2B: THE INTERNATIONAL UNION AGAINST TUBERCULOSIS & LUNG DISEASE (IUATLD) IS ACTING AS FIDUCIARY FISCAL AGENT FOR THE NORTH AMERICAN REGION (NAR) CONFERENCE. THESE FUNDS ARE USED FOR NAR-RELATED EXPENSES AND ARE FURNISHED UPON REQUEST TO THE BRITISH COLUMBIA LUNG ASSOCIATION. THESE FUNDS REPRESENTED THE BALANCE OF ALL NAR NET PROCEEDS THROUGH JANUARY 31, 2010. THESE AMOUNTS WERE PREVIOUSLY MAINTAINED BY THE AMERICAN LUNG ASSOCIATION OF THE UPPER MIDWEST AS THE SECRETARIAT. THE SECRETARIAT ROLE INCLUDED DUTIES AS SECRETARY OF THE ANNUAL CONFERENCE AND FIDUCIARY FISCAL AGENT FOR THE CONFERENCE. THE SECRETARIAT RELATIONSHIP HAS ENDED AND THE FUND BALANCE WAS REMITTED TO THE IUATLD. ALL ADDITIONAL FUNDS DIRECTED TO THE AMERICAN LUNG ASSOCIATION ARE TRANSFERRED TO THE IUATLD WHEN RECEIVED. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: IUATLD, INC. RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE IUATLD, INC. HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION. IUATLD, INC. IS NO LONGER SUBJECT TO AUDITS BY THE APPLICABLE TAXING JURISDICTIONS FOR PERIODS PRIOR TO 2007. 1 EUROPE 0 0 GRANTS TO RECIPIENTS LOCATED IN THE REGIONGRANTS TO RECIPIENTS LOCATED IN THE REGION GRANTS TO RECIPIENTS IN THE REGION 18899000 SOUTH ASIA 0 1 GRANTS TO RECIPIENTS LOCATED IN THE REGIONGRANTS TO RECIPIENTS LOCATED IN THE REGION GRANTS TO RECIPIENTS IN THE REGION; MANAGEMENT TRAINING 110023 1 0 1 19009023 0 19009023 EUROPE $17,399,000 BLOOMBERG INITIATIVE TO REDUCE TOBACCO USE; $1,500,000 TO SUPPORT STRATEGIC HEALTH INFORMATION & OPERATIONAL RESEARCH CENTER 18899000 WIRE TRANSFER N/A N/A SOUTH ASIA $110,023 TO CONDUCT INTERNATIONAL MANAGEMENT DEVELOPMENT PROGRAM COSTS 110023 WIRE TRANSFER N/A N/A 1 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: IUATLD, INC. IS BOTH A RECIPIENT AND ISSUER OF GRANT FUNDING. THE ORGANIZATION MAINTAINS A GRANT FUNDING MONITORING SYSTEM TO EFFECTIVELY MONITOR AND REPORT RESULTS OF GRANT FUNDING ISSUED TO RECIPIENTS. THIS SYSTEM FEATURES A STANDARDIZED GRANTS FUNDING AGREEMENT AND REPORTING FORMAT. VARIOUS IUATLD, INC. STAFF ARE INVOLVED IN THE SYSTEM ESTABLISHED TO ISSUE AND MONITOR GRANT FUNDS. THIS INCLUDES THE FINANCE AND OPERATIONS OFFICER, WHO OVERSEES THE PROCESS TO ISSUE GRANT FUNDING AGREEMENTS, AND THE RESEARCH AND EVALUATION COORDINATOR WHO OVERSEES DAY TO DAY MANAGEMENT OF INFORMATION RELATED TO RECIPIENT PROGRESS AND REPORTS. METHOD USED TO ACCCOUNT FOR EXPENDITURES: SCHEDULE F, PART I, LINE 3: EXPENDITURES ARE RECOGNIZED UNDER THE ACCRUAL BASIS OF ACCOUNTING. X X X X X 0 0 0 0 0 0 0 0 0 PETER BALDINI 0 215002 0 0 0 0 0 0 0 0 0 215002 0 0 PAULA FUJIWARA 250000 0 0 0 0 0 10000 0 14969 0 274969 0 0 0 ORGANIZATION MISSION STATEMENT FORM 990, PART I, LINE 1 B. SUBMISSION OF THE SYSTEMATIC REVIEW ON IGRAS IN CHILDREN FOR PUBLICATION IN THE INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE IN OCTOBER 2010. TREAT TB ALSO PROVIDED THE RESULTS OF THIS STUDY TO THE WHO EXPERT GROUP MEETING ON IGRAS IN JULY 2010 AND THE WHO STRATEGIC AND TECHNICAL ADVISORY GROUP FOR TB IN SEPTEMBER 2010. C. DEVELOPMENT AND IMPLEMENTATION OF THE SOUTH AFRICA PROVE IT PROTOCOL. THE TREAT TB CORE TEAM WORKED CLOSELY WITH PARTNERS FROM THE DESMOND TUTU TB CENTRE (DTTC) TO DEVELOP AND FINALIZE THEIR COUNTRY PROTOCOL. AFTER RECEIVING EAG APPROVAL IN LATE 2010, TREAT TB'S LOCAL PARTNER, THE DESMOND TUTU TB CENTRE, BEGAN TO IMPLEMENT THE STUDY IN EARLY 2011. D. DESIGN OF THE NATIONAL PROVE IT STUDY AND PREPARATION FOR IMPLEMENTATION IN BRAZIL. IN 2010, THE TREAT TB COORDINATION TEAM ESTABLISHED PARTNERSHIPS WITH THE KEY PLAYERS IN BRAZIL AND WORKED COLLABORATIVELY WITH THEM TO DESIGN THE STUDY PROTOCOL FOR THIS SETTING. TO PREPARE FOR THE IMPLEMENTATION OF THE PROVE IT STUDY IN BRAZIL, REDE TB STAFF HELD SEVERAL TRAINING EVENTS FOR STUDY PERSONNEL AND MEMBERS OF THE COMMUNITY ADVISORY BOARDS (CAB) IN THE THREE STUDY SITES IN ADDITION TO MULTIPLE PROVE IT MEETINGS AT REDE TB HEADQUARTERS IN RIO DE JANEIRO. E. ADAPTATION OF THE GENERIC PROTOCOL TO THE RUSSIAN CONTEXT. IN PARTNERSHIP WITH THE NORTHERN STATE MEDICAL UNIVERSITY, THE TREAT TB COORDINATION TEAM TAILORED TO THE GENERIC PROTOCOL TO ALIGN WITH THE NEEDS OF THE TB COMMUNITY IN ARKHANGELSK, RUSSIA. THE PROVE IT STUDY IN THE ARKHANGELSK REGION WILL EVALUATE THE IMPACT OF LPA ON CIVILIAN PATIENTS AS WELL AS THOSE INCARCERATED IN THE PENITENTIARY SYSTEM. F. LOCAL AND UNION ETHICS APPROVAL FOR PROVE IT STUDIES. IN ADDITION TO OBTAINING THE APPROVAL OF LOCAL ETHICS COMMITTEES IN BRAZIL, RUSSIA, AND SOUTH AFRICA, TREAT TB OBTAINED THE APPROVAL FROM THE UNION'S ETHICS ADVISORY GROUP (EAG) FOR THE SOUTH AFRICA AND RUSSIA STUDIES. THE EAG IS CURRENTLY REVIEWING THE APPLICATION AND SUPPORTING DOCUMENTS FOR THE STUDY IN BRAZIL. G. SUBMISSION OF TREAT TB SYSTEMATIC REVIEWS TO PEER-REVIEWED PUBLICATIONS. THROUGHOUT FALL 2010, TREAT TB PARTNER, MCGILL UNIVERSITY SUBMITTED THREE REVIEWS FOR PUBLICATION. THE USE OF MODS OR THIN LAYER AGAR (TLA) TECHNIQUES FOR THE DIAGNOSIS OF ACTIVE TUBERCULOSIS AND/OR DRUG SENSITIVITY TESTING: SYSTEMATIC REVIEW AND META-ANALYSIS AND THE URINARY LIPOARABINOMANNAN (LAM) ANTIGEN DETECTION FOR THE DIAGNOSIS OF TUBERCULOSIS: SYSTEMATIC REVIEW AND META-ANALYSIS ARE CURRENTLY BEING REVIEWED BY WIDELY READ PUBLIC HEALTH JOURNALS. THE INTERFERON-GAMMA RELEASE ASSAYS (IGRAS) FOR THE DETECTION OF MYCOBACTERIUM TUBERCULOSIS INFECTION IN CHILDREN REVIEW WAS ACCEPTED BY THE INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE IN LATE 2010 AND IS EXPECTED TO BE PUBLISHED IN NOVEMBER 2011. TECHNICAL PROJECT ACTIVITY 2: DEVELOPING MODELING METHODS FOR COUNTRY GUIDANCE KEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE THE: A. CREATION THE PROTOTYPE MODEL FOCUSED ON DIAGNOSTICS FOR DRUG-SENSITIVE TB. THROUGH SEVERAL PRODUCTIVE CALLS AND IN-PERSON MEETINGS, THE TEAM WAS ABLE TO DEVELOP A TWO-PRONGED MODELING APPROACH THAT UTILIZES TRANSMISSION AND OPERATIONAL MODELING. B. FINALIZATION OF THE TREAT TB MODELLING APPROACH FOR DRUG-SENSITIVE TB. TECHNICAL PROJECT ACTIVITY 3: FOSTERING COUNTRY RESEARCH TO OPTIMIZE PROGRAM PERFORMANCE KEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE THE: A. TREAT TB'S LOCAL PARTNER, THE DESMOND TUTU TB CENTRE (DTTC), CONDUCTED THE DRUG RESISTANCE IN CHILDREN STUDY. THE STUDY AIMS TO EVALUATE THE ACCESS TO CARE AMONG CHILDREN AT-RISK OF DEVELOPING DRUG-RESISTANT TB IN THE WESTERN CAPE. DTTC RECRUITED 196 CHILDREN INTO THE PREVENTATIVE TREATMENT STUDY AMONG PEDIATRIC MDR CONTACTS AND OF THESE, 112 WERE SEEN FOR FOLLOW-UP AT TWO MONTHS, 72 AT FOUR MONTHS AND 56 AT SIX MONTHS DURING THE REPORTING PERIOD. B. DTTC HAS MOVED AHEAD WITH THE DRUG RESISTANCE IN A COMMUNITY STUDY AND IS EXPECTED TO COMPLETE THE DATA ANALYSIS OF THIS STUDY'S FINDINGS BY MARCH 2011. C. TREAT TB AND DTTC IMPLEMENTED AN OPERATIONAL RESEARCH PROTOCOL DEVELOPMENT WORKSHOP WHICH RESULTED IN THE DEVELOPMENT OF 12 RESEARCH PROTOCOLS FOCUSED ON TOPICS PRIORITIZED WITHIN THE NATIONAL RESEARCH AGENDA OF SOUTH AFRICA. TWENTY-FIVE RESEARCHERS FROM LOCAL ACADEMIC INSTITUTIONS AND HEALTH DEPARTMENTS PARTICIPATED IN THE EVENT, WHICH WAS HELD AT THE LANZERAC HOTEL IN STELLENBOSCH ON MAY 10-15, 2010. D. OF THE 15 PROTOCOLS MENTIONED ABOVE, DTTC FACILITATED THE SUCCESSFUL ETHICS REVIEW OF 12. E. TREAT TB'S LOCAL PARTNERS IN MALAWI ARE COMPLETING THEIR STUDY ON OPPORTUNISTIC INFECTIONS AMONG PEOPLE INITIATING ARV TREATMENT. THE PRELIMINARY RESULTS SHOW THAT 33% OF PATIENTS WERE DIAGNOSED WITH A SERIOUS PATHOGEN ONLY BECAUSE OF THE EXTRA TESTS CONDUCTED BY THE TREAT TB STUDY TEAM. THE RESEARCH TEAM ALSO FOUND THAT 16% OF PATIENTS ENROLLED IN THE STUDY HAVE UNDIAGNOSED TB. F. TREAT TB CONVENED MEETINGS WITH USAID MISSION PERSONNEL IN INDIA AND MOZAMBIQUE TO DISCUSS SUPPORT FOR URGENT RESEARCH PROJECTS IN THESE COUNTRIES. TREAT TB AND ITS REGIONAL PARTNERS IN INDIA AND BRAZIL SUBMITTED PROPOSALS TO THE USAID MISSIONS IN NEW DELHI AND MAPUTO, MOZAMBIQUE RESPECTIVELY WHICH ARE CURRENTLY PENDING USAID REVIEW. TECHNICAL PROJECT ACTIVITY 4: DEVELOPMENT AND IMPLEMENTATION OF RESEARCH STUDIES TO IMPROVE PATIENT MANAGEMENT, TREATMENT EFFICACY AND DISEASE PREVENTION KEY RESULTS AND ACCOMPLISHMENTS IN 2010 INCLUDE: A. HOLDING A MEETING WITH ALL STUDY PARTNERS IN PARIS, FRANCE TO FINALIZE THE PROTOCOL AND DISCUSS IMPLEMENTATION ISSUES SUCH AS POSSIBLE SALVAGE REGIMENS AND THE PROCUREMENT OF REGIMEN COMPOUNDS. B. OBTAINING THE SUPPORT OF THE GREEN LIGHT COMMITTEE, WHOSE ASSISTANCE WILL ENABLE THE UNION TO PROCURE THE DRUGS FOR THE STUDY IN A TIMELY, COST-EFFECTIVE MANNER. C. MEETING WITH NTP OFFICIALS AND EVALUATED FOUR SITES IN VIETNAM, INCLUDING TWO DIFFERENT TB HOSPITALS IN HANOI, THE PHAM NGOC THACH HOSPITAL IN HO CHI MINH CITY AND A TB OUTPATIENT CLINIC AFFILIATED WITH THE PHAM NGOC HOSPITAL IN THE CENTER OF HO CHI MINH CITY. TREAT TB STAFF ALSO MET WITH THE USAID MISSION IN HANOI. D. CONDUCTING A THOROUGH ASSESSMENT OF SEVERAL POTENTIAL STREAM STUDY SITES IN SOUTH AFRICA. THE STREAM DELEGATION ALSO MET WITH USAID MISSION STAFF AND NTP OFFICIALS. E. IMPLEMENTATION VISIT TO INDIA IN NOVEMBER 2010, AS WELL AS A COMPREHENSIVE ASSESSMENT OF TWO TB HOSPITALS IN ADDIS ABABA, ETHIOPIA TO MEET WITH SENIOR MINISTRY OF HEALTH OFFICIALS. F. ORGANIZED THE FIRST STUDY MEETING WITH MEMBERS OF THE STEERING COMMITTEE ON 15 NOVEMBER 2010, DURING THE WORLD CONFERENCE ON LUNG HEALTH IN BERLIN, GERMANY. THE AIM OF THIS MEETING WAS TO DISCUSS THE IMPLEMENTATION OF THE STUDY AND THE PREPARATION COMPLETED TO DATE. G.CONDUCTED A VISIT TO NEW DELHI TO DISCUSS THE IMPLEMENTATION OF THE STREAM STUDY IN INDIA. THE STREAM RESEARCH TEAM IS IN DISCUSSION WITH NTP OFFICIALS AND POTENTIAL SITES. TECHNICAL PROJECT ACTIVITY 5: PROJECT COORDINATION, REVIEW AND SUPPORT ACTIVITIES KEY RESULTS AND ACCOMPLISHMENTS IN 2010: A. CONTINUED TO INFORM HUNDREDS OF PUBLIC HEALTH SPECIALISTS ABOUT TREAT TB'S WORK THROUGH THE BI-MONTHLY E-NEWSLETTER. B. CONVENED A TREAT TB PARTNERS MEETING IN RIO DE JANEIRO, BRAZIL ON 24-25 MAY 2010, WITH LOGISTICAL SUPPORT PROVIDED BY REGIONAL PARTNER REDE-TB, WHICH ENABLED PARTNERS AND UNION STAFF TO GAUGE PROGRESS AND PLAN THE INITIATIVE'S NEXT STEPS. THE EXPANDED SET OF COLLABORATORS AND PARTNERS WHO PARTICIPATED THIS MEETING INCLUDED MRC AND KNCV. THE LATTER HAS PROVIDED CRUCIAL ASSISTANCE IN THE IMPLEMENTATION OF THE STREAM STUDY IN SEVERAL TARGET COUNTRIES, PARTICULARLY VIETNAM. C. DISSEMINATED INFORMATION AND UPDATES ABOUT THE TREAT TB INITIATIVE ON A VARIETY OF PLATFORMS INCLUDING THE BI-MONTHLY TREAT TB E-NEWSLETTER, THE TREAT TB WEBSITE, THE UNION WEBSITE, AND EXTERNAL PUBLICATIONS RANGING FROM HEALTH-FOCUSED ONLINE MAGAZINES TO THE STOP TB QUARTERLY NEWSLETTER. THROUGH THESE EFFORTS, HUNDREDS OF GLOBAL HEALTH PROFESSIONALS RECEIVED INFORMATION ABOUT TREAT TB ACTIVITIES AND EVENTS. D. PARTICIPATED IN SEVERAL LUNG HEALTH CONFERENCES AND MEETINGS INCLUDING WHO WORKSHOPS, THE INTERNATIONAL CHILDHOOD TUBERCULOSIS MEETING, AND THE UNION'S 15TH ANNUAL NORTH AMERICAN REGION CONFERENCE. FORM 990, PART VI, SECTION A, LINE 2 MR JOSE LUIS CASTRO AND MR PETER BALDINI HAVE A BUSINESS RELATIONSHIP. THEY BOTH SERVE IN DIFFERENT CAPACITIES ON THE BOARDS OF RELATED ORGANIZATIONS. MR CASTRO ALSO SERVES AS THE PRESIDENT IUATLD, INC. FORM 990, PART VI, SECTION A, LINE 8B IUATLD, INC. HAD NO SUB-COMMITTEES OF THE BOARD IN 2010. THE GOVERNING BODY MADE ALL DECISIONS, INCLUDING ASSUMING THE RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT ACCOUNTANT. IN JANUARY 2011, HOWEVER, THE ORGANIZATION FORMED AN AUDIT COMMITTEE WITH MEMBERSHIP FROM THE BOARD. THE AUDIT COMMITTEE WILL REVIEW THE ANNUAL AUDITS, FINANCIAL STATEMENTS AND TAX RETURNS, AND OVERSEE THE SELECTION OF AN INDEPENDENT ACCOUNTANT. AUDIT COMMITTEE RECOMMENDATIONS WILL BE PRESENTED TO THE FULL BOARD FOR REVIEW AND APPROVAL. FORM 990, PART VI, SECTION B, LINE 11 IUATLD, INC. HAS ITS FORM 990 PREPARED BY AN OUTSIDE ACCOUNTING FIRM AND HAS ESTABLISHED THE FOLLOWING REVIEW PROCESS TO ENSURE THAT THE INFORMATION REPORTED IS COMPLETE AND ACCURATE. WHEN THE FORM 990 HAS BEEN PREPARED, REVIEW BY MANAGEMENT AND IS READY TO FILED WITH THE INTERNAL REVENUE SERVICE, IT IS SUBMITTED ELECTRONICALLY TO MEMBERS OF THE IUATLD, INC. BOARD OF DIRECTORS FOR ANY COMMENTS PRIOR TO ITS SUBMISSION. THE BOARD OF DIRECTORS IS PROVIDED ONE WEEK TO REVIEW THE PREPARED FORM 990, TO CONSULT WITH MANAGEMENT, AND TO PROVIDE THEIR COMMENTS. ANY COMMENTS RECEIVED ARE THEN GROUPED, SUMMARIZED AND PROVIDED TO THE COMMITTEE IN CHARGE OF FILING THE RETURN FOR THEIR REVIEW AND ACTION. EACH ISSUE IS DOCUMENTED AND ADDRESSED UNTIL THE RETURN IS FINALIZED AND APPROVED FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C IUATLD, INC. HAS IN PLACE A CONFLICT OF INTEREST POLICY WHICH IT ANNUALLY MONITORS AND ENFORCES. THE BOARD OF DIRECTORS MANDATES THAT ALL MEMBERS OF MANAGEMENT AND THE GOVERNING BODY ANNUALLY SIGN A CONFLICT OF INTEREST POLICY AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS THAT MAY EXIST. THE SIGNED POLICIES ARE SUBMITTED TO THE EXECUTIVE DIRECTOR (WHO CURRENTLY SERVES AS THE ORGANIZATION'S COMPLIANCE OFFICER) WHO REVIEWS THE SIGNED ATTESTATIONS FOR POTENTIAL OR ACTUAL CONFLICTS. (IN THE ABSENCE OF A DEDICATED COMPLIANCE OFFICER, THE PRESIDENT OF THE BOARD OF DIRECTORS CURRENTLY PERFORMS THIS FUNCTION FOR THE POLICY SUBMITTED BY THE EXECUTIVE DIRECTOR). IF POTENTIAL OR ACTUAL CONFLICTS OF INTEREST EXIST, PROPER NOTIFICATIONS ARE MADE, AND RESULTS OF INVESTIGATIONS ARE SUMMARIZED AND REPORTED TO THE BOARD OF DIRECTORS. IF ACTUAL CONFLICTS EXIST, THE INDIVIDUAL(S) INVOLVED ARE NOT ALLOWED TO VOTE OR BE A PART OF ANY DECISIONS ABOUT ANY SUCH TRANSACTIONS THAT RELATE TO THE CONFLICT UNTIL SUCH TIME AS THERE IS NO LONGER A CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 IUATLD, INC. HAS ESTABLISHED A WRITTEN COMPENSATION POLICY TO BE FOLLOWED BY MANAGEMENT AND, WHEN NECESSARY, THE BOARD OF DIRECTORS IN ORDER TO ESTABLISH THE COMPENSATION FOR THE EXECUTIVE DIRECTOR AND OTHER KEY EMPLOYEES. THE POLICY MANDATES THAT EXECUTIVE-LEVEL COMPENSATION BE PERIODICALLY REVIEWED BY MANAGEMENT AND THE BOARD OF DIRECTORS AND THAT THE REVIEW PROCESS SHOULD BE FREE OF POTENTIAL CONFLICTS OF INTEREST. THE APPROVING ENTITY NEEDS TO REVIEW APPROPRIATE AND ADEQUATE DATA TO DETERMINE THE REASONABLENESS OF COMPENSATION BEING CONSIDERED. A VARIETY OF INFORMATION AND COMPARABILITY DATA ARE AVAILABLE TO DETERMINE THAT THE APPROPRIATE LEVEL OF COMPENSATION IS BEING PAID TO EXECUTIVES. THESE INCLUDE SURVEYS OF NEW YORK CITY-BASED NON-PROFIT COMPENSATION PRACTICES, COMPARABLE PACKAGES FOR KEY STAFF OF PEER ORGANIZATIONS, AND COMPENSATION PRACTICES EXPECTED BY PROJECT DONORS. DECISIONS TAKEN ON COMPENSATION LEVELS TO BE PAID MUST BE DOCUMENTED IN WRITTEN FORM TO INCLUDE THE DATES DECISIONS ARE TAKEN, THE PARTIES PRESENT DURING THE DECISION, THE FULL TERMS APPROVED AND THE COMPARABILITY DATA USED AND RELIED UPON TO MAKE THE DECISION. THE COMPENSATION REVIEW PROCESS FOR THE EXECUTIVE DIRECTOR AND SENIOR ADVISOR POSITIONS WAS UNDERTAKEN IN JANUARY 2009. THE EXECUTIVE DIRECTOR'S COMPENSATION LEVEL WAS SET BASED ON A NUMBER OF FACTORS IN ADDITION TO THE ONES DESCRIBED ABOVE, INCLUDING COMPARABLE COMPENSATION LEVELS FOR A) NEW YORK CITY-BASED EXECUTIVES OVERSEEING NOT FOR PROFIT ORGANIZATIONS AND AFFILIATE OFFICES OF INTERNATIONAL ORGANIZATIONS, B) PUBLIC HEALTH PROFESSIONALS WITH 15-20 YEARS EXPERIENCE IN PROJECT MANAGEMENT, PARTNERSHIPS AND OPERATIONS AND LASTLY THE SALARY EXPECTATIONS OF KEY DONORS TO IUATLD, INC.-COORDINATED PROJECTS. THE SENIOR ADVISORS COMPENSATION LEVEL WAS SET BASED ON A NUMBER OF FACTORS INCLUDING COMPARABLE COMPENSATION LEVELS FOR U.S. BASED MEDICAL DOCTORS WHO A) HAVE A VERY HIGH LEVEL OF CLINICAL EXPERIENCE IN THE TREATMENT, CONTROL AND PREVENTION OF TUBERCULOSIS AND HIV/AIDS, B) HAVE AT LEAST TWENTY YEARS OF EXPERIENCE IN MANAGING COMPLEX PUBLIC HEALTH PROGRAMS, INTERNATIONAL RESEARCH PROJECTS AND INTERNATIONAL TECHNICAL ASSISTANCE PROJECTS IN DEVELOPING COUNTRY SETTINGS AND C) HAVE DEEP EXPERIENCE IN WORKING WITH U.S. GOVERNMENT TECHNICAL AGENCIES AND DONORS INVOLVED IN GLOBAL LUNG HEALTH INITIATIVES. FORM 990, PART VI, SECTION C, LINE 19 IUATLD, INC. MAKES ITS FORM 990 AVAILABLE FOR PUBLIC INSPECTION AS REQUIRED UNDER SECTION 6104 OF THE INTERNAL REVENUE SERVICE CODE BY POSTING IT TO GUIDESTAR AND OTHER SIMILAR TYPES OF WEBSITES. IN ADDITION, ALL FORMS 990, AS WELL AS FINANCIAL STATEMENTS, THE CONFLICT OF INTEREST POLICY AND OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON WRITTEN REQUEST AT IUATLD, INC. OFFICES LOCATED AT 61 BROADWAY, SUITE 1720, NEW YORK, NY 10006 OR BY CALLING THE ORGANIZATION DIRECTLY AT (212) 500-5720. OVERSIGHT OF THE AUDIT OF THE FINANCIAL STATEMENTS AND ACCOUNTANT SELECTION FORM 990, PART XI, LINE 2C: THIS PROCESS DID NOT CHANGE FROM THE PRIOR YEAR. ALTHOUGH, IUATLD, INC. DOES NOT HAVE ANY AUDIT COMMITTEE, THE GOVERNING BODY ACTS IN THAT CAPACITY AND MAKES ALL DECISIONS. WORLD LUNG FOUNDATION 61 BROADWAY NEW YORK NY 10006 202432410 TOBACCO REDUCTION/HEALTH RESEARCH INITIATIVE NY 501(C)(3) 509(A)(3) INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE INC 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 WORLD LUNG FOUNDATION C 17399523 CASH WORLD LUNG FOUNDATION N 315001 COST